HAL vs OBIO · P/E 9.3, $19.05B cap vs rev $2.6M
Halliburton Company (HAL) versus Orchestra BioMed Holdings Inc. (OBIO) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Orchestra BioMed Holdings Inc. (OBIO) is a biotechnology company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported OBIO revenue for 2024-12-31 was $2.6M. Net income was -$61.0M. Revenue was down 4.4% from 2023-12-31 to 2024-12-31. OBIO currently screens at market cap $231.7M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. OBIO currently screens at market cap $231.7M.
Not investment advice. Open the HAL and OBIO stock pages for the full models.
Not investment advice.